| Term 
 | Definition 
 
        | * Beta lactam, no other ring attached * Only active on G- aerobes * Resists most Beta lactamases of G- * Binds penicillin protein 3--> filamentouc, lysable bacteria * IV/IM, unchanged excretion. Adjust dose for renal failure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * not a beta lactam * IV/IM, oral for local effect in GIT * For MRSA or Staph with patient allergic to beta lactam * Local action against C diff * Prevents removal of D-Ala in muramic acid cell wall and thus prevents cross linking. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Red Man Syndrome- flushing from vessel dilation * Hypotension, tachycardia, shock. *Nothing to do with IgE, just drug on body action-causes histamine release * Nephrotoxicity (with other nephrotoxic drugs) Ototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * NOT Beta lactam, inhibits cell wall synthesis * Cidal vs various G+ cocci and bacilli * NEPHROTOXIC * Lipid carrier bactoprenol carries NAG-NAM to outside via dephosphorylation * Bacitracin complexes w pyrophosphate to prevent dephosphorylation. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * topical for minor cuts and scrapes * ophthalmic ointment for ulcerative blepharitis and bacterial conjunctivitis * Often used with other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Used for short course Tx of uncomplicated UTI in women * Mechanism:This blocks the addition of phosphoenolpyruvate to UDP-N-acetylglucosamine, the 2nd step in the in the synthesis of Park Nucleotide. Inhibits cell wall synthesis@font-face {   font-family: "Times New Roman"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }p.MsoFooter, li.MsoFooter, div.MsoFooter { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }table.MsoNormalTable { font-size: 10pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; } * Inhibits cell wall synthesis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Amino sugars attached to glycosidic links to an aminocyclitol ring * very polar polycations * IV route, orally cleans out bowel * Mechanism Enters G- via porin down gradient, enters cell, inhibits protein synthesis * Cidal |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides, ways to Inhibit Protein Synthesis |  | Definition 
 
        | 1. Inhibit initiaion of protein synthesis 2. Make faulty proteins misreading mRNA 3. Premature terminations, polyribosome turns to monoribosome. Responsible for postantiobiotic effect |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides Side Effects |  | Definition 
 
        | * Attain highest levels in renal cortex> reversible nephrotoxicity * Endolymph> irreversible ototoxicity * Degeneration of auditory nerve can lead to permanent hearing loss       Auditory Sx: tinnitus, high freq hearing loss       Vestibular: vertigo, ataxia, loss of balance * Can accumulate in fetus! ototoxicity in neonates |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *(generic) topical cream/ointment for burns, wounds *prevent catheter infections, opthalmic for superficial ocular infection(then called Genoptic) * IV Aminoglycosides   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Generally intechangeable with gentamicin * Possibly less ototoxic than gentamicin * IV Aminoglycosides   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * enzyme resistant for nosocomial infections that resist gentamicin and tobramycin *IV Aminoglycoside |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Neomycin and Paromomycin * Neomycin prep for bowel surgery, topical antiinfectant *Paromomycin kills cysts of Entamoeba histolytica which cause amebic dysentery |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * CL= (140-Age) x(lean wt in kg)           ------------------------------           72 x Serum Creatinine (mg/dL) For WOMEN multiply 0.85 Only distribute in lean body mass due to polycationic nature do not distribute in total body mass/water. |  | 
        |  | 
        
        | Term 
 
        | Lean Body Weight calculation |  | Definition 
 
        | * MALE=50kg _2.3 kg for each inch over 5ft * Female- 45.5 kg + 2.3 kg for each inch over 5 ft. * Aminoglycoside dose: Maximum daily dose x estimated CL/normal CL |  | 
        |  | 
        
        | Term 
 
        | Normal Creatinine Clearance |  | Definition 
 
        | * For a 70 kg male, dosing 1x/day monitor trough * Dose is 2-3x/day, monitor peak and trough levels * Know the trough and peak are notable different for Amikacin vs. Gent and Tobra |  | 
        |  | 
        
        | Term 
 
        | Other Side Effects of Aminoglycosides |  | Definition 
 
        | * Neuromuscular Block by 1.Blocking Ca++ uptake into nerve terminal> prevent Ach release 2. Block postsynaptic Ach Receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Broad spectrum static vs G=/G- and some intracellular organisms * Lipid soluble * Undergo enterhepatic cycle to have persistant drub levels * Inihibt binding of aminoacyl tRNA to ribosome. Inhibit translation *Grouped on duration of activity |  | 
        |  | 
        
        | Term 
 
        | Short Acting Tetracycline |  | Definition 
 
        | * 6-8 hours * Tetracycline is name of drug. * For acne |  | 
        |  | 
        
        | Term 
 
        | Intermediate Acting Tetracyclines |  | Definition 
 
        | * Act for about 12 hrs * Demeclocycline * For chronic dilutional hyponatremia in the syndrome of ADH (too much ADH) * inhibits protein kinase in gut of renal tubule whee ADH depends to act   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * 16-18 hrs * Doxycycline oral and parental, lipidphilic! * Minocycline (next card) |  | 
        |  | 
        
        | Term 
 
        | Minocycline Characteristics |  | Definition 
 
        | * Long lasting tetracycline *originally for acne * Associated with pulmonary complications eg pulm lupus, hypersensitivity pneumonitis, pleural effusions * Immunomodulatory and anti-inflammatory activity * Neuroprotective? * pigments nail skin sclera, thyroid, gums>not reversible |  | 
        |  | 
        
        | Term 
 
        | Minocycline Immunmodulatory Examples |  | Definition 
 
        | * Blocks synthesis of NO * Activates microglia, decreasing neuronal damage * Improved stroke outcome given 6-24 hours afer stroke * Neuroprotecting in Parkinson, Huntington's ALS< MS< Moderately effective RA |  | 
        |  | 
        
        | Term 
 
        | Tetracycline General Side Effects |  | Definition 
 
        | * GI Upset- Take w food * permanent brown teeth * Slowed growth photosensitivity esp w demeclocycline * Expired Rx> Fanconi like syndrome from nephrotoxic metabolite epianhydrotetracycline> nausea vomitting, polyuria, polydipsia, glucosuria, aminoaciduria, hyperchloremic metabolic acidosis * absorption decreased by dairy and antacids |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Parenteral, long acting * Derivative of minocycline w similar side effects * Same Mech. as tetracycline, cidal in some species. * Greater acitvity vs tetracycline sens G+ G- and MRSA from greater hindrance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Lactone ring + 1 or more deoxy sugars * All active against MRSA   |  | 
        |  | 
        
        | Term 
 
        | Macrolide Mechanism of action |  | Definition 
 
        | * inhibit translocation from A to P site * Release peptidyl tRNA form ribosomes * Block formation of initiation complex |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Active against Legionella * Metabolites complex with w cytochrome heme, Fe+2, inhibit CYP3A4 * Prokinetic, can bind and stimulate GI motility via motilin receptors. Stimulates peristalsis, speeds gastric empyting |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Large lactome ring * Mostly static sometimes Cidal * Active against methicillin sensitive aureas, Moraxella catarrhalis, H. influenza * Increase digoxin activity * Immunomodulatory, esp clarithromycin *Prolongs repolarization via K+ Channel effect> Torsades de pointes |  | 
        |  | 
        
        | Term 
 
        | Erythromycin Side Effects |  | Definition 
 
        | * Can prolong cardiac repolarization> Torsades de pointes. Increased risk if used w another Rx that inhibits CYP3A4>increases erythromycin * Binds heme, inhibiting CYP3A4, increasing its and other drugs' levels ie dilitiazem, verapamil * For some reason increases risk of sudden death   |  | 
        |  | 
        
        | Term 
 
        | Azithromycin Characteristics |  | Definition 
 
        | * Now used for Legionellas, community acquired pneumonia, mycobacterium avium complex * Concentrates intracellularly * long half life 70 hrs  Doesn't inhibit P450 * excreted unchanged in bile |  | 
        |  | 
        
        | Term 
 
        | Clarithromycin Characteristics |  | Definition 
 
        | * For community acquired pneumonia and mycobacterium avium complex * Immunomodulatory: inhibit trancription for proinflammatory cytokines * Inhibits CYP3A:            Caution using with colchicine (used for      gout)>increase risk of colchicine toxicity. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * Ketolides are macrolide derivatives with better G+ activity * Same mechanism as macrolides but binds 2 separate domains on ribosomes to recrease risk of resistance and have broader activity. * |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * A ketolide * Used for community acquired respiratory infections * Concentrates in pulmonary tissues and WBCs * Active vs Beta lactam and macrolide resistant organisms * Inhibits CYP3A4 Prolongs Q-T interval * Rarely, serious hepatotoxicity BBW Contraindicated if myasthenia gravis, life threatening respiratory failure |  | 
        |  | 
        
        | Term 
 
        | Tigecycline Uses and Side Effects |  | Definition 
 
        | * complicated skin and intraabdominal infections, community acquires bacterial pneumonia * Side effects: N&V, increased risk of mortality if hopsital acquires pneumonia, esp if ventilator asspciated, complicated intra ab infection or complicated skin and skin structure infection *Hepatic excretion, decrease dose if hepatic impairment |  | 
        |  |